Priprava i ex vivo evaluacija TEC kao promotora apsorpcije tvari u kolonu by PARISA YOUNESSI et al.
Oral absorption of protein and peptide drugs is hindered by their high molecular
mass, hydrophilicity and susceptibility to the proteolytic enzymes in the gastrointestinal
tract (1). Therefore, various approaches, such as absorption enhancers, alternative routes
and protease inhibitors, have been examined to overcome the delivery problems of these
peptides and proteins through the gastrointestinal tract (2).
Deacetylation of chitin, the second most abundant biopolymer isolated from insects,
crustaceans such as crab and shrimp as well as from fungi, leads to poly-(1,4)-D-glu-
cosamine or the so called chitosan (3) with excellent biodegradable and biocompatible
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In previous studies, it was established that chitosan and
its quaternized derivatives are potent enhancers of hy-
drophilic compounds absorption across intestinal epithe-
lia. The aim of this study was to evaluate the application
of a new quaternized chitosan, triethyl chitosan (TEC), in
pharmaceutical approaches. TEC was synthesized by a
one step process via a 22 factorial design to optimize the
preparation conditions. In ex vivo experiments, everted
rat colon sac was used to determine the effect of TEC on
the penetration of hydrophilic compounds of different
molecular masses (e.g., sodium fluorescein and brilliant
blue) through colonic epithelia in comparison with chi-
tosan at pH 7.4. These studies indicated a significant in-
crease in absorption of sodium fluorescein and brilliant
blue in the presence of TEC compared to chitosan. TEC
bearing positive charge is able to interact with the tight
junctions of colon epithelia and hence increas the perme-
ation of sodium fluorescein and brilliant blue through
the tight junctions. This investigation has shown that tri-
ethyl chitosan could be used as a penetration enhancer
for poorly absorbable compounds in the colon drug de-
livery system.
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characteristics. Because of their permeation enhancing effect, enzyme inhibitory capabi-
lities, and mucoadhesive properties, chitosan and its derivatives are important excipi-
ents for peroral peptide delivery systems. Chitosan acts by opening tight junctions be-
tween epithelial cells to allow the paracellular transport of hydrophilic molecules (4).
Moreover, there has recently been an increasing interest in targeting peptide and
protein drugs as well as oligonucleotides and vaccines to the colon because of the rela-
tively low activity of proteolytic enzymes and their long residence time in colon. In ad-
dition, it is more effective to treat colonic diseases such as ulcerative colitis, colorectal
cancer and Crohn’s disease with a direct delivery of drugs to the affected area (2).
Chitosan is a polycation with an apparent pKa 5.5 and thus, in neutral and basic en-
vironments as found in the large intestine, the chitosan molecules will lose their charge
and precipitate from solution (5).
However, it has been shown that N-trimethyl chitosan chloride (TMC), a partially
quaternized derivative of chitosan with superior solubility (6) could be a useful polymer
for the drug delivery system in the large intestine and colon, where a neutral and basic
environment prevails (7).
Different alkylated chitosans have been reported (8, 9). One of the relatively new
derivatives of chitosan is N-triethylated chitosan (TEC), which has not yet been intro-
duced into pharmaceutical approaches. In this investigation, TEC was synthesized and
evaluated as a potential absorption enhancer of hydrophilic compounds including bril-
liant blue and sodium fluorescein. The present study is continuation of our in vitro and
ex vivo studies with different alkylated chitosans as absorption enhancers.
EXPERIMENTAL
Materials
Chitosan (98% deacetylated, viscosity of 1% m/V solution is 264 mPa s) was a gift
from Primex (Iceland). Ethyl iodide was obtained from Sigma (Austria). Sodium hydrox-
ide, N-methyl pyrrolidone (NMP), sodium iodide, sodium fluorescein (Mr 332) and bril-
liant blue (Mr 792) were purchased from Merck (Germany). All chemicals and solvents
were of pharmaceutical and analytical grade and were used as received.
Methods
Synthesis and identification of TEC. – TEC was synthesized as previously described (9).
Briefly, chitosan was dispersed in 8 mL of N-methyl pyrrolidone and stirred with a mag-
netic stirrer for 4 hours at room temperature. Then, aqueous sodium hydroxide (20%, m/V)
solution (1.2 mL), sodium iodide (480 mg) and 3 mL ethyl iodide were added. The mixture
was heated at 60 °C for 6 hours under stirring. The product chitosan–N+(CH2CH3)3I–
was precipitated with acetone and separated by centrifugation. To exchange I– with Cl–,
the polymer was dissolved in 4 mL of 10% aqueous sodium chloride solution. The polymer
was precipitated with acetone, centrifuged and dried to obtain a white water-soluble
powder in quantitative yield.
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The 1H NMR spectrum was recorded in D2O using a 500 MHz spectrometer (Bru-
cker AC500, USA) and the degree of quaternization was calculated. The chemical shift
(, ppm) was adjusted with external standard (dioxane in D2O).
Ex vivo evaluation. – According to the requirement of the local Ethical Committee,
healthy male Wistar rats weighing 200–250 g (three groups of animals, 3 animals in each
group), were anesthetized with ether. Animals were kept under 12-h light/dark con-
ditions at 22 ± 1 °C, and fasted for about 12 h prior to the experiment. After verification
of the loss of the pain reflex, a midline incision was made and a segment of large intes-
tine (about 3.5 cm) was quickly removed and washed gently with Krebs Ringer Bicar-
bonate (KRB) solution sodium chloride 118 mmol L–1, sodium hydrogencarbonate 25
mmol L–1, potassium dihydrogenphosphate 1.19 mmol L–1, calcium chloride 1.03 mmol
L–1, magnesium sulfate 1.2 mmol L–1, glucose 5 mmol L–1and albumin 1% pH = 7.4) and
everted by means of a plastic rod inserted through the lumen. One end of the colon was
tied to a needle and the opposite end was tied securely (10, 11). Then, 1 mol sodium
fluorescein or brilliant blue was added to 0.5% TEC in 100 mL KRB, the sac was placed
into the solution and saturated with O2 and CO2 maintained at 37 °C. Control solutions
were prepared without the dissolved TEC polymer. One mL of KRB solution was in-
serted with a needle to the inside compartment of the sac (12, 13).
Serial samples of an known volume were taken from the inside compartment by
means of an insulin syringe every 10 minutes for 1.5 or 2 hours and each time, the vol-
ume was replaced with fresh solution (12). The absorbed amounts of sodium fluorescein
and brilliant blue were detected by a spectrophotometer NovospecII (UK) at 494 and 634
nm, respectively.
Statistical analysis
The data are expressed as the mean ± SD. For statistical analysis, the two-way ana-
lysis of variance was used and followed by Tukey’s HSD as post-hoc test to compare the
means.
RESULTS AND DISCUSSION
A one step synthesis of TEC was carried out (9). The synthesis was based on nu-
cleophilic substitution of chitosan’s amine protons with ethyl groups of an ethyl iodide
in the presence of sodium iodide and sodium hydroxide in water/NMP medium.
It was shown that a strong inorganic base, such as NaOH, was more suitable than
organic bases (such as amines with similar alkalinity to that of chitosan) to neutralize
the acidity of hydrophilic acid produced by the reaction. Studies have shown that so-
dium hydroxide and ethyl iodide are the two most effective reaction variables in the
synthesis of triethyl chitosan (10). Table I shows four reaction conditions in triplicate ba-
sed on the experimental design. Optimum amounts of the reactants were found to be
37.5 mmol of ethyl iodide (3.0 mL) and 6 mmol NaOH (1.2 mL, 20%) (formulation A4,
Table I), as the highest degree of quaternization (66%) was achieved.
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The 1H NMR spectrum of TEC is shown in Fig. 1. The signal at 1.2 ppm was attri-
buted to the CH3 groups of the ethyl substituent, while H2–H6 protons of the polysac-
charide backbone superimposed the CH2 groups. The intense band at 4.8 ppm was re-
lated to HDO (a proton-exchanged species of D2O with OH and amine). In this region,
as observed more clearly from an extended spectrum, three anomeric protons (H1S) ap-
peared at 4.23, 4.98 and 5.1 ppm. They were attributed to the mono-N-acetylglucosamine
unit, mono and di-N-alkyl substitued glucosamine units, respectively. The integral of
these signals as well as the CH3 of ethyl groups were used to calculate the degree of qua-
ternization (11).
A model rat cannulated everted intestine could eliminate the possible variables due
to blood flow and permit serial sampling from the serosal contents (13). Moreover, the
everted intestinal sac has the advantage of simplicity and flexibility (12). Barthe et al.
(14) noted that the values explained in caco-2 cell monolayers, which is one of the estab-
lished in vitro models for intestinal epithelia, might exaggerate the potential of polymers
for realistic absorption enhancement. The everted intestinal sac model may give more
realistic values for intestinal function (15).
Using inverted sacs for absorption studies an O2 and CO2 mixture was bubbled into
intestinal mucosa to increase or obtain peristaltic intestinal movement.
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Table I. The effect of reaction conditions on the degree of quaternization





Fig. 1. 1H NMR spectrum of
triethyl chitosan chloride (de-
gree of quaternization 66%) in
D2O.
In the present study we have shown that TEC, which has better solubility than chi-
tosan and does not need an acidic environment for its activity, has significantly increa-
sed the intestinal absorption of both sodium fluorescein and brilliant blue compared to
chitosan (Figs. 2a and 2b). TEC, with the involvement of actin filaments of the intestinal
epithelium, was able to increase the permeation of the hydrophilic compounds through
the tight junctions. It has been reported that chitosan induces a redistribution of cyto-
skeletal F-actin and the ZO-1 protein, thereby altering the integrity of tight junctions
(16). Confocal laser scanning microscopy has also confirmed that chitosan and TMC are
able to open the tight junctions to allow the paracellular transport of large hydrophilic
compounds (17, 18).
In addition, TEC effectiveness as permeation enhancer is more pronounced in the
case of fluorescein compared to brilliant blue probably due to the lower molecular mass
of fluorescein (19).
CONCLUSIONS
It has been shown that TEC with superior water solubility could be a potential ab-
sorption enhancer of hydrophilic compounds, including sodium fluorescein and bril-
liant blue, in colon and is promising for colon-specific drug delivery.
It has been also concluded that the potential use of TEC can be an important contri-
bution to the development of effective delivery systems for hydrophilic compounds such
as peptide drugs, especially in the more neutral and basic environment of the large in-
testine and colon where the efficacy of chitosan as an absorption enhancer is not so strong.
However, more in vitro studies in caco-2 cell and in vivo experiments are required to con-
firm TEC as an enhancing agent.
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Fig. 2. a) Sodium fluorescein alone (), added chitosan (), added TEC () (n = 3); b) brilliant
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S A @ E T A K
Priprava i ex vivo evaluacija TEC kao promotora apsorpcije tvari u koloni
PARISA YOUNESSI, MOHAMMAD REZA AVADI, KOOROUSH SHAMIMI, ASSAL MIR MOHAMMAD SADEGHI, LEILA
MOEZI, ELAHEH NAHID, KHOSROW BAYATI, AHMAD REZA DEHPOUR i MORTEZA RAFIEE-TEHRANI
U ranijim istra`ivanjima utvr|eno je da su kitozan i njegovi kvaternizirani derivati
sna`ni promotori apsorpcije hidrofilnih spojeva kroz intestinalnu sluznicu. Cilj rada bio
je evaluirati novi kvaternizirani kitozan, trietilkitozan (TEC). TEC je sintetiziran u jed-
nom stupnju. U ex vivo eksperimentima na kolonu {takora pra}en je u~inak tog polimera
na penetraciju hidrofilnih spojeva razli~itih molekulskih masa (fluorescein natrija i bri-
ljant plavila). Rezultati su uspore|ivani s u~inkom kitozana pri pH 7,4. Primije}eno je da
TEC zna~ajno pove}ava apsorpciju ispitivanih tvari u odnosu na nemodificirani kitozan.
TEC svojim pozitivnim nabojem dolazi u interakciju s epitelom kolona i tako pove}ava
njegovu permeabilnost. Ispitivanja ukazuju da se trietilkitozan mo`e upotrijebiti kao pro-
motor penetracije za spojeve koji se slabo apsorbiraju u kolonu.
Klju~ne rije~i: trietilkitozan, promotor apsorpcije, kolon
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